Evidence map›Paper›PMID 25009261›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2014

Soluble adenylyl cyclase is necessary and sufficient to overcome the block of axonal growth by myelin-associated factors.

Jennifer Martinez, Alexander M Stessin, Aline Campana, Jianwei Hou, Elena Nikulina, Jochen Buck, Lonny R Levin, Marie T Filbin

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.5field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 24 citations in OpenAlex.

  1. Adenylyl Cyclases as Therapeutic Targets in Neuroregeneration.International journal of molecular sciences · 2025
    Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Pharmacological modulation of the COPharmacology & therapeutics · 2018
    Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. What makes a RAG regeneration associated?Frontiers in molecular neuroscience · 2015
    Review
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Jennifer MartinezDepartment of Biological Sciences, Hunter College, New York, New York 10065, and Department of Pharmacology and.
Alexander M StessinDepartment of Pharmacology and Stitch Radiation Oncology Department, Weill Cornell Medical College, New York, New York 10065.
Aline CampanaDepartment of Biological Sciences, Hunter College, New York, New York 10065, and.
Jianwei HouDepartment of Biological Sciences, Hunter College, New York, New York 10065, and.
Elena NikulinaDepartment of Pharmacology and.
Jochen BuckDepartment of Pharmacology and.ORCID http://orcid.org/0000-0002-3568-5869
Lonny R LevinDepartment of Pharmacology and llevin@med.cornell.edu.
Marie T FilbinDepartment of Biological Sciences, Hunter College, New York, New York 10065, and.
Hunter College · USCornell University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neurons in the CNS do not regenerate following injury; regeneration is blocked by inhibitory proteins in myelin, such as myelin-associated glycoprotein (MAG). Elevating neuronal levels of the second messenger cAMP overcomes this blocked axonal outgrowth. One way to elevate cAMP is pretreating neurons with neurotrophins, such as brain-derived neurotrophic factor (BDNF). However, pleiotropic effects and poor bioavailability make exogenous administration of neurotrophins in vivo problematic; therefore, alternative targets must be considered. In neurons, two families of adenylyl cyclases synthesize cAMP, transmembrane adenylyl cyclases (tmACs), and soluble adenylyl cyclase (sAC). Here, we demonstrate that sAC is the essential source of cAMP for BDNF to overcome MAG-dependent inhibition of neurite outgrowth. Elevating sAC in rat and mouse neurons is sufficient to induce neurite outgrowth on myelin in vitro and promotes regeneration in vivo. These results suggest that stimulators of sAC might represent a novel therapeutic strategy to promote axonal growth and regeneration.

Indexed as

Adenylyl CyclasesAnimalsAxonsCell EnlargementCells, CulturedCerebellumCHO CellsCricetulusEnzyme ActivationMiceMice, KnockoutMyelin-Associated GlycoproteinMyelin ProteinsNerve RegenerationNeurogenesisRatsAdenylyl CyclasesMyelin-Associated GlycoproteinMyelin Proteinsaxonal regenerationBDNFcAMPsoluble adenylyl cyclase

Identifiers

PMID25009261
PMCPMC4087207
OpenAlexW2047821288

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.